You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API DOXORUBICIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing DOXORUBICIN HYDROCHLORIDE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride 0069-3030 HYDROCHLORIC ACID
Pfizer Laboratories Div Pfizer Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride 0069-3030 SODIUM CHLORIDE
Pfizer Laboratories Div Pfizer Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride 0069-4004 HYDROCHLORIC ACID
Pfizer Laboratories Div Pfizer Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride 0069-4004 SODIUM CHLORIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing DOXORUBICIN HYDROCHLORIDE

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9084 HYDROCHLORIC ACID
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9084 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9084 WATER
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9088 HYDROCHLORIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for DOXORUBICIN HYDROCHLORIDE

Excipient focus: AMMONIUM SULFATE

Excipient focus: CHOLESTEROL

Excipient focus: HISTIDINE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROGENATED SOYBEAN LECITHIN

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT

DOXORUBICIN HYDROCHLORIDE drug variants not containing N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT

Company Ingredient NDC
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-3030
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-4004
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-4030
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9084
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

DOXORUBICIN HYDROCHLORIDE drug variants containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

Company Ingredient NDC
Baxter Healthcare Corporation doxorubicin hydrochloride 0338-0063
Baxter Healthcare Corporation doxorubicin hydrochloride liposome 0338-0080
Padagis US LLC doxorubicin hydrochloride 0574-0930
Sun Pharmaceutical Industries Inc doxorubicin hydrochloride 47335-049
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

DOXORUBICIN HYDROCHLORIDE drug variants not containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

Company Ingredient NDC
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-3030
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-4004
Pfizer Laboratories Div Pfizer Inc doxorubicin hydrochloride 0069-4030
Hikma Pharmaceuticals USA Inc doxorubicin hydrochloride 0143-9084
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SUCROSE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group